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Background
Innovative biotechnology firms play major roles in the
development of biotechnology industry because of their
product innovations. Since 2005, the Malaysian govern-
ment has increased support towards the biotechnology
sector to drive this industry forward. The aim of this
paper was to identify the challenges in developing bio-
technology industry from the prospective of private bio-
technology firms in Malaysia.
Materials and methods
Mixed method approach was applied in the study which
consisted of 16 semi structured interviews with key infor-
mants from companies and an expert group discussion
among industry leaders from private sectors. Qualitative
information from these sources was integrated with the
information from the secondary sources such as govern-
ment official reports, published documents and the com-
pany websites. Only the companies that applying modern
biotechnology to produce health related products were
included. Qualitative data was transcribed using Transcri-
ber 5.0 and analyzed with Atlas.ti 6.0 software.
Results
The study results present that 1) Lack of funding was the
most common challenge for all the small medium startup
companies. 2) Lack of human capital and essential skill
sets was the major barrier for this knowledge driven
industry to growth. 3) Poor linkages/interactions between
public and private sectors was the main reason for the
huge gap in knowledge creation, dissemination across
sectors and the root of the conflicts in identifying niche
areas.4) Lack of clear regulatory paths/ guidelines for the
companies to register their products to access the local
market. 5) Lack of knowledge on biotechnology and
related aspects among government officers, decision
makers was one of the crucial factors to build an effective
regulatory system to support the growth of biotechnology
companies.
Conclusions
Biotechnology in Malaysia is facing many critical chal-
lenges such as lack of effective financial mechanisms,
essential skills set, clear regulatory pathways and so on.
Thus, building of an effective national innovation system
and prioritizing the basic research science can be key
solutions for sustainable development of biotechnology
industry.
Author details
1United Nation University-International Institute for Global Health, Universiti
Kebangsaan Malaysia Medical Centre, Jalan Yaacob Latif, 56000 Kuala
Lumpur, Malaysia. 2Department of Health Information, Universiti Kebangsaan
Malaysia Medical Centre, Jalan Yaacob Latif, 56000 Kuala Lumpur, Malaysia.
Published: 27 November 2012
doi:10.1186/1471-2458-12-S2-A25
Cite this article as: Abuduxike et al.: Main challenges in developing
biotechnology industry in Malaysia: perspectives from the innovative
biotechnology firms. BMC Public Health 2012 12(Suppl 2):A25.
1United Nation University-International Institute for Global Health, Universiti
Kebangsaan Malaysia Medical Centre, Jalan Yaacob Latif, 56000 Kuala
Lumpur, Malaysia
Full list of author information is available at the end of the article
Abuduxike et al. BMC Public Health 2012, 12(Suppl 2):A25
http://www.biomedcentral.com/1471-2458/12/S2/A25
© 2012 Abuduxike et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
